-
admin
Posts
Global Feminine Hygiene Industry Report 2024, Featuring Procter & Gamble, Kimberly-Clark, Edgewell Personal Care, Johnson and Johnson and Unicharm
Dublin, June 20, 2024 (GLOBE NEWSWIRE) — The “Opportunities in the Global Feminine Hygiene Sector 2024” report has been added to ResearchAndMarkets.com’s offering. The global...
Summerize Your Skincare with Science-Backed Hydration from ALASTIN Skincare®
A Media Snippet accompanying this announcement is available by clicking on this link. ORLANDO, Fla., June 20, 2024 (GLOBE NEWSWIRE) — National Hydration Day, June...
The Nair Experience: Unveiling Smooth, Radiant Skin This Summer
A Media Snippet accompanying this announcement is available by clicking on this link. ORLANDO, Fla., June 20, 2024 (GLOBE NEWSWIRE) — Summer’s on the horizon,...
Unilever Digital Transformation Strategy Analysis Report 2024: Accelerators, Incubators, and Other Innovation Programs
Dublin, June 20, 2024 (GLOBE NEWSWIRE) — The “Unilever – Digital Transformation Strategies” company profile has been added to ResearchAndMarkets.com’s offering. The report provides comprehensive...
Top 7 Trends in Health and Beauty for 2024: Mental Wellness, Sleep Hygiene, Beauty Inside-Out, Influencer Fatigue Trend, Affordable Wellness Trend, Thoughtful Aging Trend and Urban Protection
Dublin, June 20, 2024 (GLOBE NEWSWIRE) — The “Industry Insights: Top Trends in Health and Beauty 2024” report has been added to ResearchAndMarkets.com’s offering. This...
C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development
TUCSON, Ariz. and CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, June 20, 2024 (GLOBE NEWSWIRE) — Critical Path Institute (C-Path), a leader in forming collaborations...
Mustang Bio Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
WORCESTER, Mass., June 20, 2024 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s...
BioVie to Present Protocol Design for Upcoming Phase 2 Trial of Bezisterim in Patients with Early Parkinson’s Disease at 2024 ATMRD Congress
Additional presentation will further characterize the potential impact of bezisterim on motor and specific non-motor symptoms of Parkinson’s disease CARSON CITY, Nev., June 20, 2024...
Recce Pharmaceuticals Announces Addition of RECCE® 327 to The World Health Organization’s List of Antibacterial Products in Clinical Development
Inclusion underscores significance of RECCE® 327 (R327) in combating antimicrobial resistance and its potential to treat broad range of life-threatening and resistant bacteria SYDNEY, June...
Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing Research
Bionano has entered into a software marketing agreement with Revvity, Inc. (Revvity) under which Revvity will market and commercialize Bionano’s VIA™ software to Revvity’s next...